Obesity medicines: decisions and safe follow-up

The decision is not based only on weight or appearance. Other conditions, previous support, current medicines and preferences matter. A clinician must verify the appropriate product and conditions of use in Türkiye; overseas approval lists cannot simply be applied here.

Some medicines affect hunger and fullness signals, others fat absorption. None guarantees identical results or makes nutrition support unnecessary. An injection is not automatically better than surgery. Associated thyroid or other conditions are assessed, but weight loss is not universally impossible until every test value normalises.

Treatment may be long term, and weight can increase after stopping. This calls for a revised plan, not personal blame. Weight-loss medicines should not be used during pregnancy or while planning it; discuss breastfeeding, contraception and surgical preparation before starting. Do not change dose or brand yourself.

GLP-1 medicines can cause nausea, vomiting or diarrhoea; promptly report inability to keep fluids down or markedly reduced urine. Severe persistent abdominal pain, possibly spreading to the back, needs immediate assessment rather than being dismissed as routine. Sudden vision loss is also urgent. Call 112 for loss of consciousness or severe breathing difficulty and name the medicine.